News Sentiment

QNRX sentiment intelligence

Quoin Pharmaceuticals Ltd DRC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.24 Week of 17 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-4.7% over one week, -8.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Cash flow from financing activities of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction -4.7% Price reacting lower
Trend fit Trend inactive -8.8% over four weeks
Fair value -90.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 32
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 7
Market source 7
Stock Titan 6
GlobeNewswire 5
Moomoo 4
MT Newswires 3
simplywall.st 3
Sahm 2

Event Lens

What the news is about

Classified themes
Market update 21
Regulatory and legal 12
Earnings 10
Analyst action 3
Balance sheet 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-48 of 48
TradingKey Direct company coverage

Quoin Pharmaceuticals Ltd (QNRX) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Quoin Pharmaceuticals Ltd (QNRX)'s financial health, indicating a current financial score of 6.96, which ranks 180 out of 389 in the Biotechnology & Medical Research industry. It notes the company's robust financial status but low operating eff

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 09:11
Source
TradingKey